Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Maintenance with Weekly Carfilzomib in Elderly Newly Diagnosed Multiple Myeloma (IFM 2012-03)

Arthur Bobin, Guillemette Fouquet, Alain Duhamel, PU/PH, Salomon Manier, MD PhD, Lionel Karlin, MD, Brigitte Kolb, MD, Mourad Tiab, MD, Carla Araujo, MD, Nathalie Meuleman, PhD MD, Jean Valère Malfuson, MD, Pascal Bourquard, MD, Pascal Lenain, MD, Arnaud Jaccard, MD PhD, Karim Belhadj, MD, Michel Attal, MD PhD, Philippe Moreau, MD, Cyrille Hulin, MD, Xavier Leleu, MD PhD

Blood (2019) 134 (Supplement_1): 3190.

https://doi.org/10.1182/blood-2019-131793

Published: 2019

Journal Articles

Clinical Outcome Associated with Cytomegalovirus (CMV) Infection/Disease in CMV-Seropositive Adult Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Regis Peffault De Latour, Patrice Chevallier, MD, Didier Blaise, Aurore Clement, Thierry Allavoine, Abir Tadmouri, PhD, Josefin Blomkvist, Alain Duhamel, PU/PH, Ibrahim Yakoub-Agha, MD PhD

Blood (2018) 132 (Supplement 1): 3382.

https://doi.org/10.1182/blood-2018-99-112151

Published: 2018

Journal Articles

Triage Scoring System Based on Early Post-Transplant Complications for Patients with Myelodysplastic Syndrome Requiring ICU after Allo-HCT: An SFGM-TC Study

Blood (2016) 128 (22): 3470.

https://doi.org/10.1182/blood.V128.22.3470.3470

Published: 2016

Journal Articles

Contribution of IPSS-R Cytogenetics to Predict Outcome after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: A Study from the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC)

Jordan Gauthier, MD, Damaj Gandhi, MD PhD, Carole Langlois, MD, Marie Robin, MD PhD, Patrice Chevallier, MD PhD, Yves Beguin, MD PhD, Stephanie Nguyen, MD PhD, Pierre Bories, MD, Didier Blaise, MD PhD, Jerome Cornillon, Aline Clavert, Mohamad Mohty, MD PhD, Anne Huynh, MD, Anne Thiebaut, MD, Stephane Vigouroux, MD, Alain Duhamel, MDPhD, Ibrahim Yakoub-Agha, MD PhD

Blood (2014) 124 (21): 5609.

https://doi.org/10.1182/blood.V124.21.5609.5609

Published: 2014

Journal Articles

Clinical and prognostic implications of low or high level of von Willebrand factor in patients with Waldenström macroglobulinemia

Benedicte Hivert, Claudine Caron, Stephanie Petit, Cecile Charpy, Corinne Fankam-Siaka, Stephanie Lecocq, Christophe Zawadzki, Sophie Susen, Manuela Rusu, Alain Duhamel, Olivier Tournilhac, Jenny Goudemand, Pierre Morel

Blood (2012) 120 (16): 3214–3221.

https://doi.org/10.1182/blood-2011-11-388256

Published: 2012

Includes: Supplemental data

Journal Articles

Impact of Antithymocyte Globulin-Containing Conditioning Regimens on Patients Undergoing Allogeneic Stem Cell Transplantation for Progressive Myelodysplastic Syndrome: A Report From the SFGM-TC Group

Blood (2011) 118 (21): 3035.

https://doi.org/10.1182/blood.V118.21.3035.3035

Published: 2011

Journal Articles

Phase 2 Study of 2 Modalities of Pomalidomide (CC4047) Plus Low-Dose Dexamethasone as Therapy for Relapsed Multiple Myeloma. IFM 2009-02

Blood (2010) 116 (21): 859.

https://doi.org/10.1182/blood.V116.21.859.859

Published: 2010

Journal Articles

Hevylite®, a New Marker of Tumor Measurement In Waldenstrom Macroglobulinemia

Salomon Manier, Remy Dulery, Alain Duhamel, Eileen Boyle, Julien Rossignol, Jean Luc Faucompret, Brigitte Onraed, Bernadette Hennache, Annie Pietrantuono, Frederic Combat, Stephanie Poulain, Irene M Ghobrial, MD, Véronique Leblond, Stephen Harding, PhD, Xavier Leleu, MD, PhD

Blood (2010) 116 (21): 5076.

https://doi.org/10.1182/blood.V116.21.5076.5076

Published: 2010

Journal Articles

Clinical and Prognostic Implications of Low or High Level of Von Willebrand Factor (VWF) In Waldenström Macroglobulinemia (WM) Patients (pts). A Clinicopathological Study on 72 Pts

Bénédicte Hivert, Claudine Caron, Stéphanie Petit, Cécile Charpy, Corinne Fankam-Siaka, Alain Duhamel, Olivier Tournilhac, MD, PhD, Jenny Goudemand, MD, PhD, Pierre Morel

Blood (2010) 116 (21): 2438.

https://doi.org/10.1182/blood.V116.21.2438.2438

Published: 2010

Journal Articles

Identification during the follow-up of time-dependent prognostic factors for the competing risks of death and blast phase in primary myelofibrosis: a study of 172 patients

Pierre Morel, Alain Duhamel, Benedicte Hivert, Laure Stalniekiewicz, Jean-Loup Demory, Brigitte Dupriez

Blood (2010) 115 (22): 4350–4355.

https://doi.org/10.1182/blood-2009-12-255943

Published: 2010

Includes: Supplemental data

Journal Articles

Comparison of prognostic scoring systems in primary myelofibrosis

Pierre Morel, Alain Duhamel

Blood (2010) 115 (3): 745.

https://doi.org/10.1182/blood-2009-10-247254

Published: 2010

Journal Articles

International prognostic scoring system for Waldenström macroglobulinemia

Pierre Morel, Alain Duhamel, Paolo Gobbi, Meletios A. Dimopoulos, Madhav V. Dhodapkar, Jason McCoy, John Crowley, Enrique M. Ocio, Ramon Garcia-Sanz, Steven P. Treon, Veronique Leblond, Robert A. Kyle, Bart Barlogie, Giampaolo Merlini

Blood (2009) 113 (18): 4163–4170.

https://doi.org/10.1182/blood-2008-08-174961

Published: 2009

Includes: Supplemental data

Journal Articles

Immune Reconstitution Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation: The Impact of Expanding CD28 neg CD8 + T-Cells on Relapse.

Ibrahim Yakoub-Agha, MD, PhD, Pasquine Saule, Julia Salleron, Pascale Cracco, Valerie Coiteux, Leonardo Magro, Francoise Dufosse, Benedicte Bruno, Jean-Pierre Jouet, Alain Duhamel, Jean-Paul Dessaint, Myriam Labalette

Blood (2008) 112 (11): 1146.

https://doi.org/10.1182/blood.V112.11.1146.1146

Published: 2008

Journal Articles

Minor Histocompatibility Antigen Mismatches and Graft Versus Host and Relapse in High-Resolution HLA-Matched Allogeneic Hematopoietic Stem Cell Transplantation

Manuel Cliquennois, Pascale Cracco, Dominique Becuwe, Julia Salleron, Françoise Dufossé, Alain Duhamel, Jean-Pierre Jouet, Jean-Paul Dessaint, Myriam Labalette, Ibrahim Yakoub-Agha

Blood (2008) 112 (11): 60.

https://doi.org/10.1182/blood.V112.11.60.60

Published: 2008

Journal Articles

International Prognostic Scoring System (IPSS) for Waldenström’s Macroglobulinemia (WM).

Pierre Morel, Alain Duhamel, Paolo Gobbi, Meletios Dimopoulos, Madhav Dhodapkar, Jason McCoy, Enrique Ocio, Ramon Garcia-Sanz, Steven Treon, Veronique Leblond, Robert Kyle, Bart Barlogie, Giampaolo Merlini

Blood (2006) 108 (11): 127.

https://doi.org/10.1182/blood.V108.11.127.127

Published: 2006

NARROW

Maintenance with Weekly Carfilzomib in Elderly Newly Diagnosed Multiple Myeloma (IFM 2012-03)

Clinical Outcome Associated with Cytomegalovirus (CMV) Infection/Disease in CMV-Seropositive Adult Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Triage Scoring System Based on Early Post-Transplant Complications for Patients with Myelodysplastic Syndrome Requiring ICU after Allo-HCT: An SFGM-TC Study

Contribution of IPSS-R Cytogenetics to Predict Outcome after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: A Study from the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC)

Clinical and prognostic implications of low or high level of von Willebrand factor in patients with Waldenström macroglobulinemia

Impact of Antithymocyte Globulin-Containing Conditioning Regimens on Patients Undergoing Allogeneic Stem Cell Transplantation for Progressive Myelodysplastic Syndrome: A Report From the SFGM-TC Group

Phase 2 Study of 2 Modalities of Pomalidomide (CC4047) Plus Low-Dose Dexamethasone as Therapy for Relapsed Multiple Myeloma. IFM 2009-02

Hevylite®, a New Marker of Tumor Measurement In Waldenstrom Macroglobulinemia

Clinical and Prognostic Implications of Low or High Level of Von Willebrand Factor (VWF) In Waldenström Macroglobulinemia (WM) Patients (pts). A Clinicopathological Study on 72 Pts

Identification during the follow-up of time-dependent prognostic factors for the competing risks of death and blast phase in primary myelofibrosis: a study of 172 patients

Comparison of prognostic scoring systems in primary myelofibrosis

International prognostic scoring system for Waldenström macroglobulinemia

Immune Reconstitution Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation: The Impact of Expanding CD28 neg CD8 + T-Cells on Relapse.

Minor Histocompatibility Antigen Mismatches and Graft Versus Host and Relapse in High-Resolution HLA-Matched Allogeneic Hematopoietic Stem Cell Transplantation

International Prognostic Scoring System (IPSS) for Waldenström’s Macroglobulinemia (WM).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only